-
DEVELOPMENT OF A COST UTILITY MODEL TO ASSESS THE INCREMENTAL COST EFFECTIVENESS OF CONTINUOUS DUAL GLUCOSE KETONE MONITORING SYSTEM VERSUS CONTINUOUS GLUCOSE MONITORING SYSTEM IN PEOPLE WITH DIABETES
Mar 18, 2026, 21:38 PM -
REAL-WORLD EXPERIENCE AND BURDEN OF FATIGUE IN NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA: SURVEY RESULTS FROM THE ASPIRE STUDY
Mar 18, 2026, 21:38 PM -
TRENDS IN THE SURGICAL MANAGEMENT OF INGUINAL HERNIA, CHOLECYSTECTOMY, AND APPENDICITIS IN HUNGARY BETWEEN 2015 AND 2024
Mar 18, 2026, 21:38 PM -
COST-UTILITY ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE VERSUS FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL FOR MODERATE-TO-VERY SEVERE COPD IN CHINA
Mar 18, 2026, 21:38 PM -
FROM TEXT TO SIGNAL: EVALUATING LLMS FOR VALID CASE IDENTIFICATION IN PHARMACOVIGILANCE
Mar 18, 2026, 21:38 PM -
GLP-1 RECEPTOR AGONIST-ASSOCIATED THROMBOCYTOPENIA: A NOVEL/EXTENSIVE PHARMACOVIGILANCE EVALUATION FROM SOUTHERN NETWORK ON ADVERSE REACTIONS (SONAR-AI)
Mar 18, 2026, 21:38 PM -
A U.S. BURDEN OF DISEASE PROJECTION MODEL FOR NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, 2027-2035
Mar 18, 2026, 21:38 PM -
EVALUATION OF THE PCPA NEGOTIATION TIMELINE PROCESS FOR BRANDED NON ONCOLOGY DRUGS IN CANADA
Mar 18, 2026, 21:38 PM -
BUILDING HIGH-QUALITY, RESEARCH-GRADE MULTI-SOURCE MORTALITY DATABASES IN A TIMELY MANNER
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
Mar 18, 2026, 21:38 PM -
MODELLING THE COST-EFFECTIVENESS PROFILE OF RAPID GENOME SEQUENCING IN CHILDREN SUSPECTED OF RARE GENETIC DISEASES
Mar 18, 2026, 21:38 PM -
ENHANCING LONG-TERM COST-EFFECTIVENESS PROJECTIONS USING REAL-WORLD EVIDENCE-INFORMED UNCERTAINTY ANALYSIS
Mar 18, 2026, 21:38 PM -
AI-ENABLED VIRTUAL REALITY REHABILITATION: A HEALTH ECONOMIC FRAMEWORK FOR NEURO-ONCOLOGY
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGICAL CHARACTERISTICS OF DIABETIC KIDNEY DISEASE IN CHINESE PATIENTS WITH TYPE 2 DIABETES VISITING A TERTIARY CARE HOSPITAL: A RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND CLINICAL PROGRESSION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM: A REAL-WORLD STUDY (2012-2024)
Mar 18, 2026, 21:38 PM -
CLAIMS-BASED ALGORITHM OPTIONS TO IDENTIFY REDUCED LEFT VENTRICULAR EJECTION FRACTION PATIENTS WITH MITRAL OR TRICUSPID VALVE REGURGITATION AND HEART FAILURE
Mar 18, 2026, 21:38 PM -
PERFORMANCE METRICS FOR AI IN SLRS: A RAPID LITERATURE REVIEW OF GUIDELINE RECOMMENDATIONS FOR ACCEPTABLE THRESHOLDS
Mar 18, 2026, 21:38 PM -
COMPARISON OF THE PERFORMANCE OF PATIENT-MEDIATED MEDICAL RECORD RETRIEVAL AND TOKENIZATION-BASED LINKAGE TO GENERATE COMPLETE AND LONGITUDINAL REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT MODEL (BIM) OF BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE (BVD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE UNITED STATES (US)
Mar 18, 2026, 21:38 PM -
LUNG CANCER RELATED SPILLOVER EFFECT ON FAMILY MEMBER’S HEALTH-RELATED QUALITY OF LIFE: A US-BASED EMPIRICAL ANALYSIS
Mar 18, 2026, 21:38 PM
